| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,4 M € | -7.8% | 1,5 M € | +35.5% | 1,1 M € | +94.9% | 570,1 k € | -68.9% | 1,8 M € | +49.9% | 1,2 M € | +60.1% | 764,0 k € | +3.7% | 737,0 k € | +15.2% | 639,6 k € | +26.1% | 507,2 k € | +32.5% | 382,7 k € | -18.2% | 467,9 k € | |
| EBITDA | 427,4 k € | -28.8% | 600,6 k € | +176.2% | 217,5 k € | +174.6% | 79,2 k € | -91.0% | 883,2 k € | +39.8% | 631,6 k € | +191.9% | 216,4 k € | +64.4% | 131,7 k € | +16.1% | 113,4 k € | -11.7% | 128,4 k € | +17.3% | 109,4 k € | +8.3% | 101,1 k € | |
| Operating profit | 290,9 k € | -23.2% | 378,9 k € | +136.6% | 160,1 k € | +485.1% | 27,4 k € | -96.5% | 774,1 k € | +39.9% | 553,2 k € | +354.5% | 121,7 k € | +110.8% | 57,7 k € | +52.1% | 37,9 k € | -31.6% | 55,5 k € | +66.6% | 33,3 k € | -29.1% | 47,0 k € | |
| Profit/loss | 233,9 k € | -15.7% | 277,4 k € | +137.8% | 116,7 k € | +758.2% | 13,6 k € | -97.6% | 571,8 k € | +52.4% | 375,3 k € | +431.0% | 70,7 k € | +241.6% | 20,7 k € | +1041.7% | 1,8 k € | -90.0% | 18,1 k € | +201.5% | 6,0 k € | -66.3% | 17,9 k € | |
| Equity | 1,2 M € | +23.7% | 984,9 k € | -18.4% | 1,2 M € | +10.7% | 1,1 M € | +1.3% | 1,1 M € | +113.1% | 505,4 k € | +288.3% | 130,1 k € | +54.1% | 84,5 k € | +32.4% | 63,8 k € | +2.9% | 62,0 k € | +41.3% | 43,9 k € | +15.9% | 37,9 k € | |
| Total assets | 2,7 M € | +7.6% | 2,5 M € | +14.9% | 2,2 M € | +11.8% | 1,9 M € | -17.3% | 2,3 M € | +27.3% | 1,8 M € | +32.8% | 1,4 M € | +12.4% | 1,2 M € | +3.2% | 1,2 M € | -5.0% | 1,3 M € | +3.0% | 1,2 M € | +103.3% | 601,2 k € | |
| Cash | 353,1 k € | -1.5% | 358,4 k € | -2.5% | 367,5 k € | -39.1% | 603,7 k € | -12.7% | 691,6 k € | +0.8% | 686,0 k € | +113.1% | 321,9 k € | +116.2% | 148,9 k € | +28.0% | 116,3 k € | -47.0% | 219,3 k € | -21.7% | 280,2 k € | +37.6% | 203,6 k € | |
| Debts | 1,5 M € | -2.9% | 1,5 M € | +56.9% | 958,6 k € | +13.2% | 847,0 k € | -29.7% | 1,2 M € | -6.9% | 1,3 M € | +3.0% | 1,3 M € | +9.4% | 1,1 M € | +1.6% | 1,1 M € | -5.4% | 1,2 M € | +1.5% | 1,2 M € | +116.8% | 543,6 k € | |
| Staff | 7,6 | 7,7 | 7,9 | 6,6 | 6,6 | 6 | 6 | 6 | 5,9 | 4,3 | 3,3 | 3,3 | ||||||||||||
Private limited company · Gent · incorporated on 18/10/2012 · 7,6 ETP
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Eqwal Stomacare is a Private limited company incorporated in 2012. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Gent. It employs on average 7,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette